Clinical Consequences of Acquired Transfusional Iron Overload in Adults

New England Journal of Medicine

Volumn 304, Issue 6, 1981, Pages 319-324

  Schafer, Andrew I ^a   Cheron, Robert G ^a   Dluhy, Robert ^a   Cooper, Barry ^a   Gleason, Ray E ^a   Soeldner, J S ^a   Bunn, H Franklin ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IRON; PREDNISONE;

ADVERSE DRUG REACTION; ANEMIA; BLOOD TRANSFUSION; ENDOCRINE SYSTEM; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HEART; HEART CONTRACTION; HEART LEFT VENTRICLE PERFORMANCE; HEMOCHROMATOSIS; HYPOPHYSIS; INSULIN BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; LIVER; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; THERAPY;

EID: 0019349312     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198102053040603     Document Type: Article

References (30)

1. Milder M.S., Cook J.D., Stray S., Finch C.A. Idiopathic hemochromatosis. Medicine (Baltimore). 1980; 59:34-49.
2. Witzleben C.L., Wyatt J.P. The effect of long survival on the pathology of thalassaemia major. J Pathol Bacteriol. 1961; 82:1-12.
3. Wolman I.J. Transfusion therapy in Cooley#x0027;s anemia: growth and health as related to long-range hemoglobin levels: a progress report. Ann NY Acad Sei. 1964; 119:736-747.
4. Zaino E.C., Roberts R.H. Chelation therapy in chronic iron overload. Miami: Symposia Specialists, 1977: 138.
5. Jacobs A. Iron overload — clinical and pathologic aspects. Semin Hematol. 1977; 14:89-113.
6. Teichholz L.E., Kreulen T., Herman M.V., Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol. 1976; 37:7-11.
7. Lown B., Wolf M. Approaches to sudden death from coronary heart disease. Circulation. 1971; 44:130-142.
8. Steele R.G.D., Torrie J.H. Principles and procedures of statistics. New York: McGraw Hill, 1960: 107-9.
9. Liddle G.W., Island D., Meador C.K. Normal and abnormal regulation of corticotropin secretion in man. Recent Prog Horm Res. 1962; 18:125-166.
10. Levy C.L., Carlson H.E. Decreased prolactin reserve in hemochromatosis. J Clin Endocrinol Metab. 1978; 47:444-446.
11. Spark R.F., White R.A., Connolly P. Impotence is not always psychogenic: newer insights into hypothalamic-pituitary-gonadal dysfunction. JAMA. 1980; 243:750-755.
12. Hashimoto T., Miyai K., Izumi K., Kumahara Y. Gonadotropin response to synthetic LH-RH in normal subjects: correlation between LH and FSH. J Clin Endocrinol Metab. 1973; 37:910-916.
13. McNeil B.J., Holman L., Button L.N., Rosenthal D.S. Use of indium chloride scintigraphy in patients with myelofibrosis. J Nucl Med. 1974; 15:647-651.
14. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979; 28:1039-1057.
15. Cavill I., Worwood M., Jacobs A. Internal regulation of iron absorption. Nature. 1975; 256:328-329.
16. Engle M.A. Cardiac involvement in Cooley#x0027;s anemia. Ann NY Acad Sei. 1969: 119:694-702.
17. Buja L.M., Roberts W.C. Iron in the heart: etiology and clinical significance. Am J Med. 1971; 51:209-221.
18. Schellhammer P.F., Engle M.A., Hagstrom J.W.C. Histochemical studies of the myocardium and conduction system in acquired iron-storage disease. Circulation. 1967; 35:631-637.
19. Leon M.B., Borer J.S., Bacharach S.L., et al. Detection of early cardiac dysfunction in patients with severe beta-thalassemia and chronic iron overload. N Engl J Med. 1979; 301:1143-1148.
20. Risdon R.A., Barry M., Flynn D.M. Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia. J Pathol. 1975; 116:83-95.
21. Bothwell T.H., Cohen I., Abrahams O.L., Perold S.M. A familial study in idiopathic hemochromatosis. Am J Med. 1959; 27:730-738.
22. Stocks A.E., Martin F.I.R. Pituitary function in haemochromatosis. Am J Med. 1968; 45:839-845.
23. Dymock I.W., Cassar J., Pyke D.A., Oakley W.G., Williams R. Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis. Am J Med. 1972; 52:203-210.
24. Nelson R.L., Baldus W.P., Rubenstein A.H., Go V.L.W., Service F.J. Pancreatic α-cell function in diabetic hemochromatotic subjects. J Clin Endocrinol Metab. 1979; 49:412-416.
25. Lassman M.N., O#x0027;Brien R.T., Pearson H.A., et al. Endocrine evaluation in thalassemia major. Ann NY Acad Sei. 1974; 232:226-237.
26. Flynn D.M., Fairney A., Jackson D., Clayton B.E. Hormonal changes in thalassaemia major. Arch Dis Child. 1976; 51:828-836.
27. Lassman M.N., Genel M., Wise J.K., Hendler R., Felig P. Carbohydrate homeostasis and pancreatic islet cell function in thalassemia. Ann Intern Med. 1974; 80:65-69.
28. Walsh C.H., Wright A.D., Williams J.W., Holder G. A study of pituitary function in patients with idiopathic hemochromatosis. J Clin Endocrinol Metab. 1976; 43:866-872.
29. Kletzky O.A., Coston G., Marrs R.P., Bernstein G., Marsh C.M., Mishell D.R. Gonadotropin insufficiency in patients with thalassemia major. J Clin Endocrinol Metab. 1979; 48:901-905.
30. Nienhuis A.W., Peterson D.T., Henry W. Evaluation of endocrine and cardiac function in patients with iron overload on chelation therapy. In: Zaino EC, Roberts RH, eds. Chelation therapy in chronic iron overload. Miami: Symposia Specialists, 1977: 1-15.